Center of Biomedical Research Excellence in CNS Metabolism
中枢神经系统代谢生物医学卓越研究中心
基本信息
- 批准号:10557542
- 负责人:
- 金额:$ 215.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-15 至 2028-02-29
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAccountingAlzheimer&aposs DiseaseAreaBehaviorBiochemicalBioenergeticsBioinformaticsBiologyBiometryBrainBrain InjuriesCardiovascular systemCenters of Research ExcellenceCentral Nervous SystemChronicClinicalCognitionCollaborationsComplexCore FacilityData ScienceDedicationsDefectDevelopmentDiabetes MellitusDiseaseEnsureEpilepsyEquipmentExtramural ActivitiesFacultyFosteringFundingFutureGlucoseGoalsGrantHomeostasisInfrastructureInstitutionInvestmentsKentuckyLifeLinkMalignant NeoplasmsMediatorMedicineMemoryMentorsMetabolicMetabolic dysfunctionMetabolismMethodologyNervous System PhysiologyNeurologic DysfunctionsNeuronsNeurosciencesNeurosciences ResearchObesityOutcomeOxidation-ReductionParkinson DiseasePhasePilot ProjectsPositioning AttributeProcessResearchResearch PersonnelResearch Project GrantsResourcesRestRoleScientistSeverity of illnessStructureSynapsesSystemTechniquesTherapeuticTrainingTranslationsTraumatic Brain InjuryUnited States National Institutes of HealthUniversitiesbiomarker discoverybrain metabolismcohortcollaborative environmentcollegedata science resourcedefined contributiondesignglucose metabolismimaging capabilitiesinsightinstrumentationinterestinvestigator trainingmetabolomemetabolomicsmitochondrial metabolismmultidisciplinarynervous system disorderneuroinflammationneuronal excitabilityneuropathologyneurophysiologyneurotransmissionneurotransmitter biosynthesisnovelprogramsprotein TDP-43recruitskillssuccesssustainability frameworksynergismsystems researchtranslational impact
项目摘要
Central nervous system (CNS) metabolism and neuronal excitability are interdependent, and so CNS
metabolism is the biochemical basis of cognition, memory, and behavior. Dysregulation of CNS is implicated in
numerous disorders, including Alzheimer’s Disease, epilepsy, Parkinson’s disease, and brain injury, but the
mechanistic connections between CNS metabolism and disease are poorly understood. The University of
Kentucky (UK) College of Medicine has made significant investments over the last few years in investigators
with metabolic and metabolomics expertise and instrumentation to support their research efforts, which has
enhanced existing strengths in neuroscience, cancer, cardiovascular, and diabetes and obesity research.
Thus, UK proposes to establish a unique multidisciplinary Center of Biomedical Research Excellence (COBRE)
on CNS Metabolism (CNS-Met) as a strategically designed, sustainable framework that promotes leading-edge
research focused on the role of metabolic mediators of brain function and disease. The proposed
interdisciplinary center leverages highly specialized expertise in glucose biology, neuronal signaling,
mitochondrial metabolism, systems neuroscience, and data sciences as well as the presence of advanced
metabolomics and imaging capabilities to create an integrated research framework focused on CNS
metabolism. The overarching goals are to strengthen UK’s neuroscience research enterprise by providing a
thematically focused and sustainable multidisciplinary infrastructure dedicated to defining the contribution of
metabolism to CNS function and neurological diseases and to use this novel platform to develop promising and
highly-skilled, early-stage investigators in an exciting and impactful area of CNS research. To accomplish
these goals, we will meet four specific aims: (1) Develop a critical mass of funded investigators with research
programs directly related to the COBRE’s unifying theme; (2) provide strong team-based mentoring combining
basic and clinical expertise; (3) recruit new investigators to the COBRE in multidisciplinary areas of neurologic
dysfunction through pilot project grant and recruitment of junior Research Project Leaders; and (4) create
synergy among research projects via critical links to strong research centers and core facilities at UK, including
existing COBREs. Emerging synergies will be developed through three research projects, an Administrative
Core, a critical research core in Metabolomics, all linked by strong biostatistics/bioinformatics support, all of
which are critical to the proposed studies and will contribute to the development of institutional resources. The
scientific focus of the three research projects are brain metabolism interactions with neurological disease,
spanning basic and translational perspectives. This concentration of multidisciplinary expertise focused on
widely recognized yet understudied metabolic mechanisms of neurological diseases promises significant new
understandings of CNS metabolism overall. The CNS-Met will create a critical mass of skilled scientists who
are well equipped to lead a sustainable research center focused on CNS metabolism into the future.
中枢神经系统 (CNS) 代谢和神经兴奋性是相互依赖的,因此 CNS
新陈代谢是认知、记忆和行为的生化基础,中枢神经系统的失调与中枢神经系统的失调有关。
许多疾病,包括阿尔茨海默病、癫痫、帕金森病和脑损伤,但
中枢神经系统代谢与疾病之间的机制联系知之甚少。
肯塔基(英国)医学院在过去几年中对研究人员进行了大量投资
拥有代谢和代谢组学专业知识和仪器来支持他们的研究工作,
增强了神经科学、癌症、心血管、糖尿病和肥胖研究方面的现有优势。
因此,英国提议建立一个独特的多学科生物医学卓越研究中心(COBRE)
中枢神经系统代谢 (CNS-Met) 作为一个战略设计的可持续框架,可促进前沿技术的发展
研究重点是代谢介质对大脑功能和疾病的作用。
跨学科中心利用葡萄糖生物学、神经信号传导、
线粒体代谢、系统神经科学和数据科学以及先进技术的存在
代谢组学和成像能力创建专注于中枢神经系统的综合研究框架
总体目标是通过提供一个新的途径来加强英国的神经科学研究事业。
以主题为重点且可持续的多学科基础设施,致力于确定以下领域的贡献:
代谢对中枢神经系统功能和神经系统疾病的影响,并利用这个新平台进行有前途的开发和
中枢神经系统研究令人兴奋且有影响力的领域的高技能、早期研究人员。
这些目标,我们将实现四个具体目标:(1)培养一批受资助的研究人员
(2) 提供强有力的团队指导
基础和临床专业知识;(3) 为 COBRE 招募神经学多学科领域的新研究人员
通过试点项目拨款和招募初级研究项目负责人来解决功能障碍;以及(4)创建
通过与英国强大的研究中心和核心设施的关键联系,研究项目之间的协同作用,包括
现有的 COBRE 将通过三个研究项目来发展,一个是行政项目。
核心,代谢组学的关键研究核心,所有这些都通过强大的生物统计学/生物信息学支持联系起来,所有
这对拟议的研究至关重要,并将有助于机构资源的开发。
这三个研究项目的科学重点是大脑代谢与神经系统疾病的相互作用,
跨越基础和转化视角的多学科专业知识的集中。
广泛认可但尚未充分研究的神经系统疾病代谢机制有望带来重大新进展
CNS-Met 将培养一批熟练的科学家。
完全有能力领导一个专注于中枢神经系统代谢的可持续研究中心的未来。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Patrick G Sullivan其他文献
Platelet glycogenolysis is important for energy production and function
血小板糖原分解对于能量产生和功能很重要
- DOI:
10.1080/09537104.2023.2222184 - 发表时间:
2023-06-09 - 期刊:
- 影响因子:3.3
- 作者:
Kanakanagavalli Shravani Prakhya;Hemendra J. Vekaria;Daniёlle M Coenen;Linda Omali;Josh Lykins;Smita Joshi;Hammodah R Alfar;Qing Jun Wang;Patrick G Sullivan;S. Whiteheart - 通讯作者:
S. Whiteheart
Serum-Stable Gold(III) Bisphosphine Complex Induces Mild Mitochondrial Uncoupling and In Vivo Antitumor Potency in Triple Negative Breast Cancer.
血清稳定的金 (III) 双膦复合物在三阴性乳腺癌中诱导轻度线粒体解偶联和体内抗肿瘤效力。
- DOI:
10.1021/acs.jmedchem.3c00238 - 发表时间:
2023-06-06 - 期刊:
- 影响因子:7.3
- 作者:
Adedamola S Arojojoye;Chibuzor Olelewe;Sailajah Gukathasan;J. H. Kim;Hemendra J. Vekaria;S. Parkin;Patrick G Sullivan;Samuel G. Awuah - 通讯作者:
Samuel G. Awuah
Patrick G Sullivan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Patrick G Sullivan', 18)}}的其他基金
Targeting mitostasis via activation of mitochondrial biogenesis after TBI
TBI 后通过激活线粒体生物发生来靶向有丝分裂
- 批准号:
10656408 - 财政年份:2017
- 资助金额:
$ 215.98万 - 项目类别:
mitoNEET as a therapeutic target for TBI
mitoNEET 作为 TBI 的治疗靶点
- 批准号:
9240940 - 财政年份:2017
- 资助金额:
$ 215.98万 - 项目类别:
Mitochondrial Uncoupling as a Therapeutic Target in Obesity
线粒体解偶联作为肥胖的治疗靶点
- 批准号:
8645141 - 财政年份:2014
- 资助金额:
$ 215.98万 - 项目类别:
14th Annual KSCHIRT Symposium, 2008
第 14 届 KSCHIRT 年度研讨会,2008 年
- 批准号:
7541306 - 财政年份:2008
- 资助金额:
$ 215.98万 - 项目类别:
Core--Microscopy, Image Analysis and Stereology
核心——显微镜、图像分析和体视学
- 批准号:
7060633 - 财政年份:2005
- 资助金额:
$ 215.98万 - 项目类别:
Mitochondrial Uncoupling as a Therapeutic Target in TBI
线粒体解偶联作为 TBI 的治疗靶点
- 批准号:
7409966 - 财政年份:2004
- 资助金额:
$ 215.98万 - 项目类别:
Mitochondrial Uncoupling as a Therapeutic Target in TBI
线粒体解偶联作为 TBI 的治疗靶点
- 批准号:
7204185 - 财政年份:2004
- 资助金额:
$ 215.98万 - 项目类别:
相似国自然基金
套期会计有效性的研究:实证检验及影响机制
- 批准号:72302225
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
上市公司所得税会计信息公开披露的经济后果研究——基于“会计利润与所得税费用调整过程”披露的检验
- 批准号:72372025
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
全生命周期视域的会计师事务所分所一体化治理与审计风险控制研究
- 批准号:72372064
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
兔死狐悲——会计师事务所同侪CPA死亡的审计经济后果研究
- 批准号:72302197
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
环境治理目标下的公司财务、会计和审计行为研究
- 批准号:72332003
- 批准年份:2023
- 资助金额:166 万元
- 项目类别:重点项目
相似海外基金
BET-BD1 Selective Neuroimaging probes for Alzheimer's disease research
用于阿尔茨海默病研究的 BET-BD1 选择性神经影像探针
- 批准号:
10628245 - 财政年份:2023
- 资助金额:
$ 215.98万 - 项目类别:
Role of AgRP neurons in chronic stress-accelerated brain aging and progression of Alzheimer's disease
AgRP 神经元在慢性应激加速的大脑衰老和阿尔茨海默病进展中的作用
- 批准号:
10740580 - 财政年份:2023
- 资助金额:
$ 215.98万 - 项目类别:
A novel driving coach app for older adults with cognitive impairment
一款针对有认知障碍的老年人的新型驾驶教练应用程序
- 批准号:
10759329 - 财政年份:2023
- 资助金额:
$ 215.98万 - 项目类别:
Aging, PTSD, and the Anterior Cingulate Cortex (ACC)
衰老、创伤后应激障碍 (PTSD) 和前扣带皮层 (ACC)
- 批准号:
10587057 - 财政年份:2023
- 资助金额:
$ 215.98万 - 项目类别:
Wisconsin Registry for Alzheimer's Prevention
威斯康星州阿尔茨海默病预防登记处
- 批准号:
10655978 - 财政年份:2023
- 资助金额:
$ 215.98万 - 项目类别: